Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 67.09 | 214.67 | 209.92 | 1.0207 | 1.0224 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 156.25 | 67.09 | 360.33 | 209.92 | 1.7200 | 1.7879 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 67.09 | 295.00 | 209.92 | 1.4082 | 1.4677 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 156.25 | 67.09 | 276.67 | 209.92 | 1.3027 | 1.3275 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 67.09 | 216.00 | 209.92 | 1.0071 | 0.9601 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 156.25 | 67.09 | 140.33 | 209.92 | 0.6616 | 0.5434 |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 156.25 | 67.09 | 80.33 | 209.92 | 0.3866 | 0.1189 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 156.25 | 67.09 | 59.67 | 209.92 | 0.2871 | -0.0679 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 270.33 | 209.92 | 1.2716 | 1.2906 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 156.25 | 67.09 | 212.33 | 209.92 | 1.0134 | 1.0101 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 275.33 | 209.92 | 1.3292 | 1.3871 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 156.25 | 67.09 | 283.33 | 209.92 | 1.3178 | 1.3022 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 259.67 | 209.92 | 1.2186 | 1.2255 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 156.25 | 67.09 | 295.67 | 209.92 | 1.4149 | 1.4776 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 256.33 | 209.92 | 1.2311 | 1.2774 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 156.25 | 67.09 | 220.00 | 209.92 | 1.0437 | 1.0475 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 294.33 | 209.92 | 1.4153 | 1.4767 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 67.09 | 231.67 | 209.92 | 1.0967 | 1.1072 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 222.67 | 209.92 | 1.0621 | 1.0744 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 156.25 | 67.09 | 294.00 | 209.92 | 1.3713 | 1.3704 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 363.33 | 209.92 | 1.7068 | 1.7326 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 156.25 | 67.09 | 272.33 | 209.92 | 1.2750 | 1.2802 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 259.67 | 209.92 | 1.2413 | 1.2839 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 156.25 | 67.09 | 250.67 | 209.92 | 1.1858 | 1.2034 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 272.67 | 209.92 | 1.2798 | 1.2820 |